Business Standard

Pfizer working on booster shot to protect against Covid-19 variants

"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to Reuters

WHO nod for Pfizer Covid vaccine may allow better access to poor nations
Premium

However, the company added that studies needed to evaluate the booster shot are yet to be determined in agreement with regulators

Reuters
Pfizer Inc said on Tuesday that along with partner BioNTech Se it was developing a booster shot to protect against COVID-19 variants.
 
"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to Reuters.
 
However, the company added that studies needed to evaluate the booster shot are yet to be determined in agreement with regulators.
 
The story was first reported by Bloomberg News.
 
Moderna Inc, whose vaccine has also been authorized for emergency use in the United States, had said on Monday it

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in